drugset / Trial / NCT02563678

Hyperbaric Oxygen, Neutrophil-oxidative Burst, and Cytokines

NCT02563678

Phase 1 Unknown 40 enrolled Intermountain Health Care, Inc.
Non-randomizedParallel-groupOpen-labelBasic science

Summary

In this small pilot study, participants (patients and healthy volunteers) will have blood drawn before and after the study intervention (hyperbaric chamber session or normal pressure oxygen breathing. This blood will be analyzed for neutrophil oxidative burst and cytokine analysis.

Timeline

Start
2015-04
Primary completion
2023-12
Completion
2023-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxygen Other / unclassified

Indications